- Udyam number
- UDYAM-UK-05-0037042

Parb Pharmaceuticals Private Limited
About Parb Pharmaceuticals Private Limited
Data last updated:
Parb Pharmaceuticals Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 16 November 2022.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24304UR2022PTC014870. Its GSTIN is 05AANCP3666K1ZX (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹1 Lakh. It is led by directors including Konic Goyal and Anuj Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dehradun, Uttarakhand.
As per the financials filed for FY 2025, the company reported a revenue of ₹59.42 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹8.33 Cr (net margin 14%) and EBITDA of ₹10.77 Cr (EBITDA margin 18.1%).
Parb Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-UK-05-0037042). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Parb Pharmaceuticals
Contact details
Parb Pharmaceuticals Private Limited's registered office is in Dehradun, Uttarakhand.
- Registered AddressE – 9 Sector – Sidc, Iie Selaqui, Dehradun, Uttarakhand, India – 248011
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Parb Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Parb Pharmaceuticals Private Limited, buy the company report.
Financials of Parb Pharmaceuticals Private Limited
FY 2025 filings availableParb Pharmaceuticals Private Limited reported revenue of ₹59.42 Cr (up 2461% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹10.77 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹8.33 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 18.1% | ||
| Net Profit Margin | 14% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Parb Pharmaceuticals Private Limited, buy the company report.
Board of directors of Parb Pharmaceuticals Private Limited
Parb Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anuj Kumar Also directs: Parb Bioceuticals Private Limited | Additional Director | 29 Aug 2023 | 3 Years 2 Months | Current |
| Manic Goyal | Additional Director | 23 Sep 2023 | 3 Years 1 Months | Current |
| Konic Goyal | Director | 16 Nov 2022 | 3 Years 11 Months | Current |
Peer comparison
Parb Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Arbro Pharmaceuticals Private Limited | ₹64.16 Cr (FY 2025) | -9.0% | Delhi, India | |||
| MDC Pharmaceuticals Limited | ₹61.89 Cr (FY 2024) | 14.0% | Chandigarh, India | |||
| Lok-Beta Pharmaceuticals (India )Private Limited | ₹60.2 Cr (FY 2024) | 40.0% | Mumbai, Maharashtra, India | |||
| Parb Pharmaceuticals Private Limitedthis company | ₹59.42 Cr (FY 2025) | ₹8.33 Cr | 14% | 2461.0% | Dehradun, Uttarakhand, India | |
| Vaasavaa Pharmaceuticals Private Limited | ₹59.28 Cr (FY 2025) | 16.0% | Solapur, Maharashtra, India | |||
| Solistaa Pharmaceuticals Private Limited | ₹57.79 Cr (FY 2025) | 8.0% | Puducherry, India | |||
| Stedman Pharmaceuticals Private Limited | ₹57.77 Cr (FY 2024) | 9.0% | Chennai, Tamil Nadu, India | |||
| Accretion Pharmaceuticals Limited | ₹57.47 Cr (FY 2025) | 329.0% | Sanand, Gujarat, India | |||
| Alidac Pharmaceuticals Limited | ₹57.16 Cr (FY 2019) | -60.0% | Matoda, Gujarat, India |
To see the full peer comparison of Parb Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Parb Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Parb Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Parb Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AANCP3666K1ZX | Uttarakhand | Active | 27 Dec 2022 |
To see the full GST registrations and return filing status of Parb Pharmaceuticals Private Limited, buy the company report.
Recent activity
Parb Pharmaceuticals Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Manic Goyal was appointed as Additional Director on 23 Sep 2023.
Frequently asked questions
Parb Pharmaceuticals is an active private limited company based in Dehradun, Uttarakhand, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 16 November 2022 (4+ years old) and is registered under CIN U24304UR2022PTC014870.
Parb Pharmaceuticals has 3 current directors:
- Anuj Kumar - Additional Director
- Manic Goyal - Additional Director
- Konic Goyal - Director
The latest financial statements of Parb Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Parb Pharmaceuticals is 05AANCP3666K1ZX, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Parb Pharmaceuticals is U24304UR2022PTC014870. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Parb Pharmaceuticals was incorporated on 16 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Parb Pharmaceuticals by revenue are Arbro Pharmaceuticals Private Limited, MDC Pharmaceuticals Limited, Lok-Beta Pharmaceuticals (India )Private Limited, Vaasavaa Pharmaceuticals Private Limited, Solistaa Pharmaceuticals Private Limited and 3 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manic Goyal was appointed as Additional Director on 23 Sep 2023. Parshotam Lal Goyal ceased to be Director on 21 Sep 2023. Anuj Kumar was appointed as Additional Director on 29 Aug 2023. Parb Pharmaceuticals has 4 board changes on record in total.
Yes, Parb Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-UK-05-0037042).
The registered office of Parb Pharmaceuticals is at E – 9 Sector – Sidc, Iie Selaqui, Dehradun, Uttarakhand, India – 248011.
Parb Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.

